Having been a patient facing a death sentence, I discovered my passion, my purpose in life was to improve the experience and the outcomes for future patients. I set out to impact the healthcare system by creating new models of innovation so the industry might be as advanced and as revered as the tech industry. By establishing innovation centers such as the San Jose BioCenter, the Environmental Business Cluster and Janssen Labs, and educational programs like the UC Berkeley BioExec Institute, we have helped scientists and entrepreneurs deliver real solutions to real patients and we have fostered a networked community that is creating new lifelines for future patients. I never imagined the impact and reach we could have, and yet, it was only scratching the surface.
I've always felt we needed the partnership of global corporations to leverage their resources, infrastructure and influence to catalyze genuine change in the industry. In collaborating with Johnson & Johnson over the past three years, first on Janssen Labs and most recently with Johnson & Johnson's Innovation Centers, we have found a partner who is just as passionate as we are about patients, their families and the innovators who are dedicated to bringing about transformational healthcare products.
It is with great excitement that I announce Prescience is joining forces with J&J, where we will be dedicated to expanding our impact in global innovation hotspots. As Head of Janssen Labs, I will be reporting directly to Diego Miralles, Global Head, Innovation, Janssen Pharmaceuticals. In this new role, I along with the Prescience team members, will expand J&J's external R&D engine; adding capital efficient infrastructure, high impact services, technical and funding programs and strong networks to provide unparalleled access and engagement with entrepreneurial communities around the globe. We will also continue to support the growth of the Johnson & Johnson Innovation Centers and the development of critical services to support early stage company growth.
We look forward to continue to partner with you as we foster a new era in healthcare solutions where people, ideas, and technologies intersect; where we have an open exchange of ideas and collaboration; where we build custom solutions for the right opportunities; where we create new experiences and outcomes for patients.
Together we can transform patient care and build a healthier future.
Melinda
Melinda Richter Founder & CEO, Prescience International
Janssen Pharmaceuticals, Inc., a pharmaceutical company of Johnson & Johnson, provides medicines for an array of health concerns in several therapeutic areas, including: attention deficit hyperactivity disorder (ADHD), general medicine (acid reflux disease, infectious diseases), mental health (bipolar I disorder, schizophrenia), neurologics (Alzheimer’s disease, epilepsy, migraine prevention and treatment), pain management, and women’s health.
Our ultimate goal is to help people live healthy lives. We have produced and marketed many first-in-class prescription medications and are poised to serve the broad needs of the healthcare market – from patients to practitioners, from clinics to hospitals.
Headquartered in Titusville, New Jersey, Janssen is named after Dr. Paul Janssen, a leading Belgian researcher, pharmacologist, and general practitioner. Dr. Janssen led a group of researchers to discover a medicine that helped change the way mental health patients were treated. His company, Janssen Pharmaceutica, joined the Johnson & Johnson family of companies in 1961. Our company remains guided by Dr. Janssen’s values of excellence and innovation.
We invite you to visit our sister companies, Janssen Biotech and Janssen Therapeutics, which share in our vision of advancing patient care.
The Arizona Fall League is reserved for a handful of players who are deemed to have star pedigree. AAA is for anybody that might be handy one day - like the back ups to the back ups. But I get what you're saying and agree.
News 
Market Data 
Discover 
AI
